April 1, 2022
COVID-19 Booster Dose Update (AIM)
This talking points document was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide updated information on COVID-19 vaccine booster doses.
March 4, 2022
International HPV Awareness Day Talking Points
These talking points highlight data surrounding HPV infections & vaccinations, routine adolescent immunizations, & pandemic effects on routine vaccinations.
February 25, 2022
How Can Faith Leaders Help Support the COVID-19 Vaccination Effort?
This resource provides faith-based organizations with tools to assist in stopping the spread of COVID-19.
February 22, 2022
How Can Community-Based Organizations Help Support the COVID-19 Vaccination Effort?
This resource provides community-based organizations (CBOs) with tools to assist in stopping the spread of COVID-19.
February 18, 2022
How to Keep Communities Engaged in the Fight Against Flu As We Combat COVID-19
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu…
January 7, 2022
COVID-19 Vaccine Update and Updated Quarantine/Isolation Recommendations
This e-learning module was developed by the iREACH team to provide a suite of materials containing comprehensive information on flu disease and flu vaccine.
December 22, 2021
First Approved Oral Antiviral Pill for COVID-19 Disease
This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.
December 17, 2021
December 2021 ACIP Recommendation on Johnson & Johnson Vaccine
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the ACIP recommendation regarding the Johnson & Johnson COVID-19 vaccine.
December 3, 2021
COVID-19 Omicron (B.1.1.529) Variant
This talking points document was developed by the iREACH Subject Matter Experts to provide information on the COVID-19 Omicron variant.
October 4, 2021
Communicating the Benefits of Influenza Vaccine
AIM and IAC share “Communicating the Benefits of Influenza Vaccine During COVID-19” -recommendations on co-administration of flu and COVID-19 vaccines and tips.